SAKK 01/18 Reduced intensity radio-chemotherapy for satge IIA/B seminoma. A multicenter, open label phase II trial with 2 cohorts
|
abstract
|
Main objective: To investigate efficacy of a stage-adapted tratment
regimen in stage IIA/B seminoma based on the preliminary experience
gained in SAKK 01/10. The Goal is to further safely de-escalate
Treatment while maintaining / enhancing efficacy.
|
| |
|
|
type of project
|
clinical studies
|
|
status
|
ongoing - recruiting phase
|
|
start of project
|
2019
|
|
end of project
|
2030
|
|
study design
|
multicenter, open Label Phase II with two cohorts
|
|
responsible person
|
PD Dr. paul Martin Putora
|
additional links & downloads
